Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 26, 2026 | May 28, 2026 |
| Cencora, Inc.COR · Entity 2994 | Director · Executive Chairman | September 16, 2025 | September 18, 2025 |
| Elevance Health, Inc.ELV · Entity 2934 | Director | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 42,003 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 15,842 · Balance 42,003 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Cencora, Inc.
Report date September 16, 2025 · Filed September 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 305,912.665 |
Ending reported balance
After 2025-09-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-09-16 · Exercise / conversion · Acquired 29,350 · Balance 337,262.665 Row 2 · 2025-09-16 · Sale · Disposed 31,350 · Balance 305,912.665 F1: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24. F2: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple tranches ranging from $287.372 to $292.625 inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in the footnote. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.09 · Expires 2026-11-13 | Direct | 58,699 |
Reported balance
After 2025-09-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-09-16 · Exercise / conversion · Disposed 29,350 · Balance 58,699 F3: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24.
F2: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple tranches ranging from $287.372 to $292.625 inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in the footnote.
F3: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.
Elevance Health, Inc.
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,202 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 563 · Balance 4,202 F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2021 Filed Mar 17, 2021 20:07 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 12,783 | $0.00 Strike: $98.24 | $0.00 |
DisclosureSEC source: 0001127602-21-011017 · form4.xml · derivative · entry 5 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,623 Underlying: Common Stock · 12,783 shares Expires 2022-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. F3 · derivative.exercise_date: Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:07 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 18,667 | $0.00 Strike: $88.71 | $0.00 |
DisclosureSEC source: 0001127602-21-011017 · form4.xml · derivative · entry 4 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,333 Underlying: Common Stock · 18,667 shares Expires 2021-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/12/15, 11/12/16, 11/12/17 and 11/12/18 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:07 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 33,697 | $112.71 | $3,797,988.87 |
DisclosureSEC source: 0001127602-21-011017 · form4.xml · nonDerivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,810 F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:07 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 12,783 | $98.24 | $1,255,801.92 |
DisclosureSEC source: 0001127602-21-011017 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:07 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 18,667 | $88.71 | $1,655,949.57 |
DisclosureSEC source: 0001127602-21-011017 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,419 | $0.00 Strike: $88.71 | $0.00 |
DisclosureSEC source: 0001127602-21-005206 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: Common Stock · 1,419 shares Expires 2021-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments on 11/12/15, 11/12/16, 11/12/17 and 11/12/18 Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 1,419 | $108.08 | $153,365.52 |
DisclosureSEC source: 0001127602-21-005206 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,057 Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 1,419 | $88.71 | $125,879.49 |
DisclosureSEC source: 0001127602-21-005206 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:08 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 700 | $0.00 Strike: $88.71 | $0.00 |
DisclosureSEC source: 0001127602-21-004664 · form4.xml · derivative · entry 6 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,419 Underlying: Common Stock · 700 shares Expires 2021-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/12/15, 11/12/16, 11/12/17 and 11/12/18 Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:08 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 700 | $110.08 | $77,056.00 |
DisclosureSEC source: 0001127602-21-004664 · form4.xml · nonDerivative · entry 4 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,057 F1 · balance_after: The share amounts correct previously misstated totals. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:08 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 700 | $88.71 | $62,097.00 |
DisclosureSEC source: 0001127602-21-004664 · form4.xml · nonDerivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:08 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 73,951 | $0.00 Strike: $88.71 | $0.00 |
DisclosureSEC source: 0001127602-21-004664 · form4.xml · derivative · entry 5 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,119 Underlying: Common Stock · 73,951 shares Expires 2021-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/12/15, 11/12/16, 11/12/17 and 11/12/18 Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:08 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 83,951 | $110.36 | $9,264,832.36 |
DisclosureSEC source: 0001127602-21-004664 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,057 Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:08 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 73,951 | $88.71 | $6,560,193.21 |
DisclosureSEC source: 0001127602-21-004664 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 20,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-029113 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant F2 · derivative.exercise_date: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant F2 · derivative.expiration_date: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | Tax withholdingCommon Stock | 8,973 | $108.12 | $970,160.76 |
DisclosureSEC source: 0001127602-20-029113 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,036 Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 20,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-029113 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:03 UTC | Cencora, Inc. ABC · Entity 2994 | Tax withholdingCommon Stock | 41,750 | $96.92 | $4,046,410.00 |
DisclosureSEC source: 0001127602-20-028961 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,393 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:03 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 96,021 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028961 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:04 UTC | Cencora, Inc. ABC · Entity 2994 | GrantRestricted Stock Units · Derivative | 38,155 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028761 · form4.xml · derivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,155 Underlying: Common Stock · 38,155 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on November 10, 2021, 2022, and 2023, respectively. F1 · price: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on November 10, 2021, 2022, and 2023, respectively. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on November 10, 2021, 2022, and 2023, respectively. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on November 10, 2021, 2022, and 2023, respectively. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:42 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,904 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-20-021274 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,904 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:42 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,904 | $100.59 | $2,002,143.36 |
DisclosureSEC source: 0001127602-20-021274 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:42 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,904 | $68.49 | $1,363,224.96 |
DisclosureSEC source: 0001127602-20-021274 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:02 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,905 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-20-019209 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,904 Underlying: Common Stock · 19,905 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 19, 2019. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:02 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,905 | $101.62 | $2,022,746.10 |
DisclosureSEC source: 0001127602-20-019209 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 19, 2019. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 20:02 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,905 | $68.49 | $1,363,293.45 |
DisclosureSEC source: 0001127602-20-019209 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 19, 2019. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:05 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,905 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-20-015403 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,809 Underlying: Common Stock · 19,905 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:05 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,905 | $86.25 | $1,716,806.25 |
DisclosureSEC source: 0001127602-20-015403 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:05 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,905 | $68.49 | $1,363,293.45 |
DisclosureSEC source: 0001127602-20-015403 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 20:04 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,905 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-20-013380 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,714 Underlying: Common Stock · 19,905 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 20:04 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,905 | $84.75 | $1,686,948.75 |
DisclosureSEC source: 0001127602-20-013380 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 20:04 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,905 | $68.49 | $1,363,293.45 |
DisclosureSEC source: 0001127602-20-013380 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,905 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-20-010077 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,619 Underlying: Common Stock · 19,905 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:06 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,905 | $81.74 | $1,627,034.70 |
DisclosureSEC source: 0001127602-20-010077 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 19, 2019. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,905 | $68.49 | $1,363,293.45 |
DisclosureSEC source: 0001127602-20-010077 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 19, 2019. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:21 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,905 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-20-004850 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,524 Underlying: Common Stock · 19,905 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:21 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,905 | $93.20 | $1,855,146.00 |
DisclosureSEC source: 0001127602-20-004850 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 21:21 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,905 | $68.49 | $1,363,293.45 |
DisclosureSEC source: 0001127602-20-004850 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 21:16 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,905 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-20-001276 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,429 Underlying: Common Stock · 19,905 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17 Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 21:16 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,905 | $84.42 | $1,680,380.10 |
DisclosureSEC source: 0001127602-20-001276 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| January 06, 2020 Filed Jan 7, 2020 21:16 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,905 | $68.49 | $1,363,293.45 |
DisclosureSEC source: 0001127602-20-001276 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,905 | $0.00 Strike: $68.49 | $0.00 |
DisclosureSEC source: 0001127602-19-034761 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,334 Underlying: Common Stock · 19,905 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/14, 11/13/15, 11/13/16 and 11/13/17 Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 19,905 | $86.97 | $1,731,072.16 |
DisclosureSEC source: 0001127602-19-034761 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 19,905 | $68.49 | $1,363,293.45 |
DisclosureSEC source: 0001127602-19-034761 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective June 19, 2019 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on June 25, 2019. Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 21:17 UTC | Cencora, Inc. ABC · Entity 2994 | OtherCommon Stock | 7,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033676 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,122 F1 · shares: The reporting person transferred 7,544 shares of AmerisourceBergen common stock to his ex-wife pursuant to a divorce settlement. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:36 UTC | Cencora, Inc. ABC · Entity 2994 | Tax withholdingCommon Stock | 3,556 | $82.33 | $292,765.48 |
DisclosureSEC source: 0001127602-19-032852 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,666 Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:36 UTC | Cencora, Inc. ABC · Entity 2994 | GrantCommon Stock | 8,178 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-032852 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,222 F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:36 UTC | Cencora, Inc. ABC · Entity 2994 | GrantRestricted Stock Units · Derivative | 22,651 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-032852 · form4.xml · derivative · entry 4 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,651 Underlying: Common Stock · 22,651 shares Expires 2026-11-13 F3 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant F3 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant F4 · derivative.exercise_date: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 21:36 UTC | Cencora, Inc. ABC · Entity 2994 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 176,099 | $86.09 Strike: $86.09 | $15,160,362.91 |
DisclosureSEC source: 0001127602-19-032852 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,099 Underlying: Common Stock · 176,099 shares Expires 2026-11-13 F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:28 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 18,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-032535 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,516 shares Expires 2023-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant F2 · derivative.exercise_price: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant F2 · derivative.exercise_date: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.